Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit
21 oct. 2024 16h00 HE
|
Nurix Therapeutics, Inc.
Presentations will summarize new preclinical data from brain-penetrant, pan-mutant B-Raf degrader program and recent clinical data from NX-5948 BTK degrader program Members of the Nurix management...